期刊文献+

氨甲环酸在心肺转流下心内直视手术麻醉中的应用 被引量:5

Clinical efficiency of tranexamic acid in cardiac patients undergoing cardiopulmonary bypass
下载PDF
导出
摘要 目的观察和评估在心肺转流手术中应用抗纤溶药氨甲环酸的疗效和安全性。方法 60例拟行心肺转流手术患者,随机分为氨甲环酸组(A组,n=30)和对照组(B组,n=30),其中A组按总量90 mg.kg-1分两次给予氨甲环酸,诱导后切皮前静注1/2量,另1/2量术中持续泵注1.0 mg.kg-1.h-1。B组给予0.9%氯化钠液9 m.lkg-1。记录两组手术前后血细胞压积(Hct)、血小板计数(P lt)、肌酐、术毕及术后24 h心包纵隔引流量和输血量,并观察过敏反应。结果与B组比较,A组术后24h心包纵隔引流量和输血量显著降低(P<0.05),无肾功能不全及过敏反应。结论在心肺转流手术中使用氨甲环酸可以明显减少术后出血量和输血量。 Aim To evaluate the efficiency and security of tranexamic acid in cardiac patients undergoing cardiopulmonary bypass.Methods 60 patients,scheduled for cardiopulmonary bypass were randomly divided into two groups with 30 patients in each group.In tranexamic acid group(group A),patients received tranexamic acid(total dosage 90 mg·kg-1),one half of total dosage was injected after induction of anesthesia,the remaining dosage was injected at a rate of 1.0 mg·kg-1·h-1 via microinfusion pump during intraoperation.In placebo group(group B),patients acted as group A injected normal saline(total dosage 9 ml·kg-1).The haematocrit(Hct),platelet counts(Plt)and level of creatinine both prime and postoperation in two groups were recorded.The postoperative mediastinal chest tube drainage during 24 hours,blood product transfusions were all recorded,and the allergic reactions for all patients were observed.Results The postoperative mediastinal chest tube drainage during 24 hours and blood product transfusions were significantly more in group B than in group A(P 0.05),and no adverse effects such as allergic reactions,renal dysfunction were observed in two groups.Conclusion The tranexamic acid was effective to reduce postoperative bleeding and blood product transfusions in cardiac patients undergoing cardiopulmonary bypass.
出处 《安徽医药》 CAS 2011年第5期615-617,共3页 Anhui Medical and Pharmaceutical Journal
关键词 氨甲环酸 心肺转流 止血药 tranexamic acid cardiopulmonary bypass hemostatic
  • 相关文献

参考文献9

  • 1Murkin JM,Falter F,Granton J.High-Dose Tranexamic Acid Is Associated with Nonischemic Clinical Seizures in Cardiac Surgical Patients[J].Anesthesia & Analgesia,2010,110(2):350-3.
  • 2Sander M,Spies CD,Martiny V,et al.Mortality associated with administration of high-dose tranexamic acid and aprotinin in primary open-heart procedures:a retrospective analysis[J].Critical care,2010,14(4):R148.
  • 3Murphy GJ,Reeves BC,Rogers CA,et al.Increased mortality,postoperative morbidity,and cost after red blood cell transfusion in patients having cardiac surgery[J].Circulation,2007,116(22):2544.
  • 4高晴云,周汝元.大剂量抑肽酶在长时间体外循环中的应用[J].安徽医药,2002,6(4):20-21. 被引量:3
  • 5孔祥,林敏,葛建军,葛圣林,周汝元.成人法洛四联症根治术108例体会[J].安徽医药,2009,13(10):1205-1206. 被引量:3
  • 6徐红梅,孙杰,唐晓阳,丁正年,钱燕宁.氨甲环酸对心肺转流患者手术出血量的影响[J].临床麻醉学杂志,2009,25(10):874-876. 被引量:7
  • 7Lambert W,Brisebois FJ,Wharton TJ,et al.The effectiveness of low dose tranexamic acid in primary cardiac surgery[J].Can J Anaesth,1998,45(6):571-4.
  • 8Armellin G,Vinciguerra A,Bonato R,et al.Tranexamic acid in primary CABG surgery:high vs low dose[J].Minerva Anest-esiol,2004,70(3):97-107.
  • 9武婷,文其祥.氨甲环酸与抑肽酶对血液保护功能的对比研究[J].中国体外循环杂志,2005,3(1):10-13. 被引量:16

二级参考文献34

共引文献25

同被引文献38

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部